A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice
Nathalie Demotte, Grégoire Wieërs, Patrick Van Der Smissen, Muriel Moser, Christopher Schmidt, Kris Thielemans, Jean Luc Squifflet, Birgit Weynand, Javier Carrasco, Christophe Lurquin, Pierre J. Courtoy, Pierre Van Der Bruggen
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice'. Together they form a unique fingerprint.